Xeltis announced today that it completed enrollment in an EU pivotal trial for aXess, its restorative vascular access conduit. The study evaluates aXess in adults with end-stage renal disease. Eindhoven, The Netherlands-based Xeltis will conduct the study in 120 subjects across 22 centers in Europe. This study follows 12-month data from a … [Read more...] about Xeltis completes enrollment in vascular access conduit study
Business
Endologix picks former Medtronic executive as new CEO
Endologix announced today that President and CEO Dr. Matt Thompson intends to step down and take on a new role. Thompson plans to transition into the position of EVP and chief medical officer. As a result, the company appointed Dr. John Liddicoat as its new president and CEO, effective immediately. Richard Mott, Endologix's board chair, said … [Read more...] about Endologix picks former Medtronic executive as new CEO
Microbot Medical announces $7M offering to support surgical robot commercialization
Microbot Medical (Nasdaq:MBOT) announced today that it entered into definitive agreements for the purchase and sale of common stock for proceeds of $7 million. The offering includes just over 4 million shares of common stock priced at $1.75 per share. In an additional concurrent private placement, the company plans to issue unregistered … [Read more...] about Microbot Medical announces $7M offering to support surgical robot commercialization
IceCure earns European patent win for next-gen cryoablation tech
IceCure Medical (Nasdaq:ICCM) announced today that it received an intention to grant notice from the European Patent Office. The notice covers the company's invention titled "Cryogenic System Connector," which recently received a patent in the U.S., too. Caesarea, Israel-based IceCure designed it to work as part of its XSense cryoablation … [Read more...] about IceCure earns European patent win for next-gen cryoablation tech
Adagio Medical picks medtech veteran Todd Usen as new CEO
Adagio Medical (Nasdaq:ADGM) announced today that it appointed Todd Usen as its new CEO and board director. Usen's appointment follows the departure of Olav Bergheim, the company's founder, CEO and board chair, effective Dec. 13. The company concurrently made Usen CEO and Orly Mishan chair of the board of directors. Bergheim intends to continue … [Read more...] about Adagio Medical picks medtech veteran Todd Usen as new CEO
FastWave raises $19M for IVL platform
FastWave Medical announced today that it closed an oversubscribed funding round worth proceeds of $19 million. Minneapolis-based FastWave, which develops intravascular lithotripsy (IVL) technologies, said the funding brings it to more than $40 million raised in total. Epic Venture Partners led the round, which had participation from M&L … [Read more...] about FastWave raises $19M for IVL platform
Vantis Vascular closes $10M Series B
Vantis Vascular announced today that it successfully closed a Series B-1 preferred financing round worth $10 million. San Jose, California-based Vantis' latest funding brings the company to $30 million raised to date. The company develops the CrossFast microcatheter guide extension system along with the CrossShock intravascular lithotripsy (IVL) … [Read more...] about Vantis Vascular closes $10M Series B
InspireMD announces CFO retirement, transition
InspireMD announced today that Craig Shore, the company's CFO, decided to retire after the company identifies and appoints a successor. Shore intends to remain as CFO until the stroke prevention company names his replacement to assist in a smooth and orderly transition. He spent 15 years at InspireMD, helping to build the business into "a global … [Read more...] about InspireMD announces CFO retirement, transition
Anteris Technologies launches IPO to support heart valve technology
Anteris Technologies today announced the launch of its initial public offering in the U.S. The company aims to raise funds through the IPO to advance the development of its DurAVR transcatheter heart valve technology. Anteris’ IPO consists of 14.8 million shares of common stock, with an additional 2.22 million shares available to underwriters … [Read more...] about Anteris Technologies launches IPO to support heart valve technology
First U.S. cases performed with Medtronic Affera ablation system
A hospital in Texas announced today that its electrophysiologists completed the first U.S. cases with the Medtronic (NYSE:MDT) Affera platform. EPs at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center performed the procedures with Affera. Dr. Andrea Natale and Dr. Amin Al-Ahmad conducted the first procedure on Nov. 7. A … [Read more...] about First U.S. cases performed with Medtronic Affera ablation system
